IndraLab
Statements
reach
"Therefore, blocking the interaction between NKG2A and CD94 can activate NK-cell activity, further inhibiting the immune escape of cancer cells.Four immune checkpoint proteins, PD-L1, TLR4, HLA-G, and NKG2A, belong to the TMEM family and can form homodimers or heterodimers to regulate cancer immunotherapy."